Delivery Order SPE2DB22D3016-SPE2DB25FBDG8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,740.75 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $9,626.23 to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $7,638.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) with an ultimate completion date of April 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $1,321.60 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Progesterone 200 mg capsules (100-count units). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, requiring completion by June 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $25,285.45. This firm fixed-price delivery order, which carries an ultimate completion date of July 29, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $13,739.88 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.40 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $4,310.34 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) under a firm fixed price contract. This delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a small-value transaction for pharmaceutical supply to support federal medical procurement needs. The award was made on a non-set-aside, competitive basis, with performance occurring at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed price contract valued at $11,828.08. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, leveraging its...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDG8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,242.11 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its ongoing support to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 7/28/25 |